Xenon Pharmaceuticals (XENE) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.31
-1.15
-0.99
-0.83

Details

Expected EPS
-1.191574
Actual EPS
-1.31
Surprise EPS
-0.12
Surprise Percent
+9.94%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -1.31 per share for Q1 2026.

0 Comments

Share your thoughts